Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To compare the angiographic and clinical outcomes of aggressive versus standard balloon preparation during drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR). The study will evaluate whether more aggressive lesion preparation with cutting/scoring/OPN balloons improves outcomes compared to standard preparation with semi-compliant or non-compliant balloons.
PICCOLETO XI A-PREP is an investigator-initiated, multicenter, international, observational study evaluating the impact of lesion preparation strategies on outcomes following drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR).
In-stent restenosis remains a clinically relevant challenge despite advances in drug-eluting stent technology and contemporary percutaneous coronary intervention techniques. DCB represents a stentless therapeutic strategy for ISR treatment, with the advantage of avoiding implantation of additional metallic layers.
A key determinant of clinical outcomes in ISR, particularly with DCB angioplasty, is the adequacy of lesion preparation before definitive therapy. Effective preparation facilitates optimal drug delivery, improves luminal gain, and may reduce the risk of recurrent restenosis.
A large spectrum of balloon-based modalities is available for ISR lesion preparation, ranging from semi-compliant and non-compliant balloons to more aggressive tools such as scoring and cutting balloons. Although more aggressive devices may enhance plaque modification and neointimal tissue disruption, their incremental clinical benefit over standard approaches remains uncertain.
Patients will be categorized into two groups based on lesion preparation strategy:
Clinical outcomes will be assessed at 1-year and longest available follow-up.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Aggressive Lesion Preparation | Patients who underwent lesion preparation using cutting/Wolverine balloons, scoring balloons (any brand), and/or OPN balloons prior to DCB angioplasty for ISR. | ||
| Standard Lesion Preparation | Patients who underwent lesion preparation using semi-compliant balloons and/or non-compliant balloons prior to DCB angioplasty for ISR. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Major Adverse Cardiovascular Events (MACE) | Composite of cardiac death, non-fatal myocardial infarction (MI), or target lesion revascularization (TLR). | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Cardiac Death | Death attributed to cardiovascular causes, including death from unknown cause. | 12 months and longest available follow-up |
| Non-fatal Myocardial Infarction | Non-fatal myocardial infarction according to the Fourth Universal Definition of Myocardial Infarction. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Lack of clinical outcome assessment
Not provided
Not provided
Not provided
Adult patients who underwent drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR) at participating centers.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Filippo Luca Gurgoglione, MD, PhD | Contact | +393312048150 | filippolucagurgoglione@gmail.com | |
| Beatrice Barbano | Contact | segreteria@fondazioneric.org |
| Name | Affiliation | Role |
|---|---|---|
| Bharat Khialani, MD | Tan Tock Seng Hospital, National Healthcare Group, Singapore | Principal Investigator |
| Filippo Luca Gurgoglione, MD, PhD | Department of Cardiology, Parma University Hospital, Parma, Italy | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40365890 | Background | Wanha W, Iwanczyk S, Tajstra M, Cortese B. How to treat coronary in-stent restenosis? Recent advances and their practical implications: State-of-the-Art Review. Kardiol Pol. 2025;83(5):556-569. doi: 10.33963/v.phj.105954. Epub 2025 May 14. | |
| 21109112 | Background | Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010 Nov 30;56(23):1897-907. doi: 10.1016/j.jacc.2010.07.028. |
Not provided
Not provided
Individual participant data may be made available to qualified researchers upon reasonable request after study completion and primary publication, subject to appropriate data use agreements and ethics committee approval.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months and longest available follow-up |
| Target Lesion Revascularization (TLR) | Any repeat revascularization (percutaneous or surgical) of the target lesion. | 12 months and longest available follow-up |
| Target Vessel Myocardial Infarction (TV-MI) | Myocardial infarction attributable to the target vessel based on clinical, electrocardiographic, and biomarker criteria. | 12 months and longest available follow-up |
| BARC Major Bleeding | Bleeding Academic Research Consortium (BARC) major bleeding events (type 3-5). | 12 months and longest available follow-up |
| Procedural Success | Successful DCB angioplasty with residual stenosis less than 30% and TIMI flow grade 3 without major procedural complications. | At procedure |
| Post-procedural Diameter Stenosis | Percentage of diameter stenosis after DCB angioplasty assessed by quantitative coronary angiography. | At procedure |
| Angiographic Dissection | Presence and type of coronary dissection after lesion preparation and DCB treatment. | At procedure |
| TIMI Flow Grade | Thrombolysis In Myocardial Infarction (TIMI) flow grade assessment post-procedure. | At procedure |
| Bernardo Cortese, MD | Fondazione Ricerca e Innovazione Cardiovascolare ETS | Study Chair |
| 21349453 | Background | Latib A, Mussardo M, Ielasi A, Tarsia G, Godino C, Al-Lamee R, Chieffo A, Airoldi F, Carlino M, Montorfano M, Colombo A. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv. 2011 Feb;4(2):155-64. doi: 10.1016/j.jcin.2010.09.027. |
| 12423707 | Background | Mauri L, Bonan R, Weiner BH, Legrand V, Bassand JP, Popma JJ, Niemyski P, Prpic R, Ho KK, Chauhan MS, Cutlip DE, Bertrand OF, Kuntz RE. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol. 2002 Nov 15;90(10):1079-83. doi: 10.1016/s0002-9149(02)02773-x. |
| 32274746 | Background | Bonaventura K, Schwefer M, Yusof AKM, Waliszewski M, Krackhardt F, Steen P, Ocaranza R, Zuhdi AS, Bang LH, Graf K, Bock U, Chin K. Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study. Adv Ther. 2020 May;37(5):2210-2223. doi: 10.1007/s12325-020-01320-2. Epub 2020 Apr 9. |
| D001161 |
| Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |